STOCK TITAN
  1. Home
  2. Sec-filings
  3. VNRX
  4. [EFFECT] VOLITIONRX LTD SEC Filing

[EFFECT] VOLITIONRX LTD SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 19, 2026 5:00 P.M.
Form: S-3
CIK: 0000093314
Company Name: VOLITIONRX LTD
File Number: 333-293314

Source: View Original Filing on SEC EDGAR

Stock VNRX logo
Volitionrx

NYSE:VNRX

VNRX Rankings

#5939 Ranked by Market Cap
N/A Ranked by Dividends

VNRX Latest News

Feb 10, 2026
Volition Announces the Appointment of New Distributor for Nu.Q® Discover
Feb 9, 2026
VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Feb 4, 2026
Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
Jan 30, 2026
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays
Jan 27, 2026
Volition Announces Data to Support Use of Nu.Q® NETs in New Indication

VNRX Latest SEC Filings

Feb 20, 2026
[8-K] VOLITIONRX LTD Reports Material Event
Feb 17, 2026
[SCHEDULE 13G/A] VOLITIONRX LTD Amended Passive Investment Disclosure
Feb 17, 2026
[SCHEDULE 13G/A] VOLITIONRX LTD Amended Passive Investment Disclosure
Feb 11, 2026
[DEF 14A] VOLITIONRX LTD Definitive Proxy Statement
Feb 9, 2026
[8-K] VOLITIONRX LTD Reports Material Event

VNRX Stock Data

27.79M
100.46M
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
HENDERSON